Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$4,378,536
+$594,210 QoQ
Shares Held
17,400
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.78%
of 13F equity value
Holder Rank
#1,396
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Center for Financial Planning, Inc. holds $12,258,532 across 12 Drug Manufacturers - General names. ABBV ranks #1 (35.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
17,400 | $4,378,536 | |
| 2 | JNJ |
Johnson & Johnson
|
15,794 | $4,011,202 | |
| 3 | MRK |
Merck & Co., Inc.
|
11,433 | $1,469,140 | |
| 4 | LLY |
ELI LILLY & Co
|
995 | $1,193,432 | |
| 5 | AMGN |
Amgen Inc
|
1,349 | $488,499 | |
| 6 | PFE |
Pfizer Inc
|
13,544 | $326,139 | |
| 7 | NVO |
Novo Nordisk A S
|
3,079 | $147,607 | |
| 8 | AZN |
Astrazeneca PLC
|
528 | $100,119 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,378,536 | 17,400 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $3,784,326 | 17,400 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,983,266 | 17,433 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,200,367 | 18,141 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,160,180 | 17,025 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,088,743 | 14,742 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,619,653 | 14,742 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,911,250 | 14,742 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $2,580,518 | 15,045 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,720,209 | 14,938 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,159,971 | 13,938 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,066,418 | 13,863 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,864,528 | 13,839 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,200,899 | 13,810 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,301,164 | 14,239 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,917,860 | 14,290 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,840,370 | 12,016 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,947,913 | 12,016 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,626,966 | 12,016 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,294,871 | 12,004 | Shares | Sole | 2021-11-17 | |
| 2021-06-30 | $1,299,077 | 11,533 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,248,101 | 11,533 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,165,256 | 10,875 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $952,541 | 10,875 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,067,707 | 10,875 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $828,566 | 10,875 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||